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Pathogenesis of Atherosclerosis
rling Falk, MD, PHD
arhus, Denmark
Atherosclerosis is a multifocal, smoldering, immunoinflammatory disease of medium-sized
and large arteries fuelled by lipids. Endothelial cells, leukocytes, and intimal smooth muscle
cells are the major players in the development of this disease. The most devastating
consequences of atherosclerosis, such as heart attack and stroke, are caused by superimposed
thrombosis. Therefore, the vital question is not why atherosclerosis develops but rather why
atherosclerosis, after years of indolent growth, suddenly becomes complicated with luminal
thrombosis. If thrombosis-prone plaques could be detected and thrombosis averted, athero-
sclerosis would be a much more benign disease. Approximately 76% of all fatal coronary
thrombi are precipitated by plaque rupture. Plaque rupture is a more frequent cause of
coronary thrombosis in men (80%) than in women (60%). Ruptured plaques are
characterized by a large lipid-rich core, a thin fibrous cap that contains few smooth muscle
cells and many macrophages, angiogenesis, adventitial inflammation, and outward remodel-
ing. Plaque rupture is the most common cause of coronary thrombosis. Ruptured plaques and,
by inference, rupture-prone plaques have characteristic pathoanatomical features that might
be useful for their detection in vivo by imaging. This article describes the pathogenesis of
atherosclerosis, how it begets thrombosis, and the possibility to detect thrombosis-prone
plaques and prevent heart attack. (J Am Coll Cardiol 2006;47:C7–12) © 2006 by the





























ntherosclerosis is by far the most frequent underlying cause
f coronary artery disease, carotid artery disease, and pe-
ipheral arterial disease. Atherosclerosis alone is rarely fatal;
t is thrombosis, superimposed on a ruptured or eroded
therosclerotic plaque, that precipitates the life-threatening
linical events such as acute coronary syndromes and stroke
1–3). Therefore, the vital question is not why atheroscle-
osis develops but rather why none or only few among many
laques within a given person apparently pass through a
hrombosis-prone and dangerous phase during a lifetime
Fig. 1) (4). That is what it is all about; preventing the
evelopment of thrombosis-prone plaques and, if they
lready are there, finding and treating those who harbor
hem and are at high risk of loosing myocardium, brain,
nd/or life. This viewpoint describes the pathogenesis of
therosclerosis with this ambitious goal in mind.
THEROGENIC STIMULI
mong the many cardiovascular risk factors, elevated
lasma cholesterol level is probably unique in being suffi-
ient to drive the development of atherosclerosis, even in the
bsence of other known risk factors (5). If all adults had
lasma cholesterol levels 150 mg/dl, symptomatic disease
ould be rare. The other risk factors, such as hypertension,
iabetes, smoking, male gender, and possibly inflammatory
arkers (e.g., C reactive protein, cytokines, and so on),
ppear to accelerate a disease driven by atherogenic lipopro-
eins, the first of which being low-density lipoprotein (LDL).
ow they do it is uncertain, but they may either increase the
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005, accepted September 19, 2005.therogenicity of LDL (e.g., particle size, number, and
omposition) or increase the susceptibility of the arterial
all (e.g., permeability, glycation, inflammation, and so on).
he importance of risk factors beyond cholesterol is clearly
ocumented by the great disparity in the expression of
linical disease among individuals with the same cholesterol
evel.
ROTECTIVE FACTORS
lcohol, exercise, and high-density lipoprotein (HDL) and
ts major apolipoprotein, apoA-I, confer protection against
iseases caused by atherothrombosis. Among other things,
DL/apoA-I prevents the atherogenic modifications of
DL and promotes “reverse cholesterol transport,” which
lows plaque progression and may induce rapid regression,
ocumented in experimental studies and suggested by serial
ntravascular ultrasound examinations of patients with acute
oronary syndrome (6,7).
USCEPTIBILITY
he limited ability to predict clinical disease based on risk
actor scores indicates that our knowledge about the indi-
idual susceptibility to atherogenic stimuli is inadequate
8–10). Experimental studies indicate that inactivation of
enes coding for monocyte chemotactic protein-1 (MCP-1),
ts receptor on monocyte/macrophages (CCR2), and mac-
ophage colony-stimulating factor has profound impact on
he development of atherosclerosis in otherwise identical
ice (5). Such disease susceptibility factors remain to be
dentified in humans.
However, the susceptibility to atherothrombosis differs
ot only among individuals with similar risk factor scores
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Pathogenesis of Atherosclerosis April 18, 2006:C7–12egments from the same individual (arterial susceptibility).
he endothelium is very sensitive to shear stress, and local
emodynamic conditions related to branching, low and
scillating shear, and reverse flow may offer some of the
xplanation for the fact that the coronary arteries are much
ore susceptible to atherosclerosis than the internal mam-
ary arteries (11).
ELLULAR COMPONENTS OF ATHEROSCLEROSIS
therosclerosis is a chronic immunoinflammatory, fibroprolif-
rative disease of large and medium-sized arteries fuelled by
ipid (5,12,13). Endothelial cells, leukocytes, and intimal
mooth muscle cells are the major players in the develop-
ent of this disease.
ndothelial cells. In lesion-prone areas, atherosclerotic
esions begin to develop under an intact but leaky, activated,
nd dysfunctional endothelium. Later, endothelial cells may
anish and de-endothelialized (denuded) areas appear over
dvanced lesions, with or without platelets adhering to the
xposed subendothelial tissue (14).
Depending on size and concentration, plasma molecules
nd lipoprotein particles extravasate through the leaky and
efective endothelium into the subendothelial space, where
otentially atherogenic lipoproteins are retained and modified
e.g., oxidized) and become cytotoxic, proinflammatory, che-
otaxic, and proatherogenic. The mechanisms responsible for
he atherogenic modification of LDL are unknown but could
nclude oxidation mediated by myeloperoxidase, 15-
ipoxygenase, and/or nitric oxide synthase (NOS) (5). Nitric
xide is a potent oxidant produced by both endothelial cells
nd macrophages that appears to exert both protective and
therogenic effects, depending on its source of production.
itric oxide produced by endothelial NOS has vasodilator
unction and is potentially atheroprotective. In contrast, nitric
xide produced via the much higher capacity inducible NOS in
acrophages, serving antimicrobial functions based on its
otent oxidative properties, is potentially proatherogenic.
The endothelium becomes activated by atherogenic and
roinflammatory stimuli, and the expression of adhesion
olecules, primarily vascular cell adhesion molecule-1
VCAM-1), are up-regulated, and monocytes and T cells
re recruited. Besides VCAM-1, other adhesion molecules,
uch as intercellular adhesion molecule-1, E selection, and P
election, probably contribute to the recruitment of blood-
orne cells to the atherosclerotic lesion (12,13).
Endothelial dysfunction as assessed clinically (impaired
Abbreviations and Acronyms
HDL  high-density lipoprotein
LDL  low-density lipoprotein
MCP-1  monocyte chemotactic protein-1
NOS  nitric oxide synthase
VCAM-1  vascular cell adhesion molecule-1itric oxide-mediated vasodilation) predicts clinical events
a
saused by atherothrombosis, and it generally is assumed that
his form of endothelial dysfunction equates with endothe-
ial activation as described previously in which atheroprotec-
ive mechanisms are lost and atherothrombosis promoted.
egarding hard clinical end points, the anti-inflammatory and
ntithrombotic properties of the endothelium, however, may
e more important than vasodilator function (15). It is indeed
hought-provoking that the mere presence of atherogenic risk
actors is associated with endothelial dysfunction not only in
therosclerosis-susceptible arteries but also in arteries that
re relatively resistant to atherosclerosis (e.g., the brachial
rtery) and even in the microcirculation. Thus, impaired
ndothelium-mediated vasodilation is related to athero-
hrombosis but not necessarily causally.
eukocytes. One of the earliest cellular responses in
therogenesis is the focal recruitment of circulating mono-
ytes and, to a lesser extent, T lymphocytes (12,13). The
ersistence of this cellular response seems to underlie disease
rogression. B lymphocytes and plasma cells are rare in the
ntimal plaque but may be abundantly present in adventitia
ext to advanced intimal disease (16). Activated mast cells
ay be found both in plaque and adventitia, particularly in
ulprit lesions causing acute ischemic events (17). Neutro-
hils are rare in uncomplicated atherosclerosis but have been
igure 1. Plaque heterogeneity within a given patient. (A) Cross section of
coronary artery cut just distal to a bifurcation. The atherosclerotic plaque
o the left (circumflex branch) is fibrotic and partly calcified, whereas the
laque to the right (marginal branch) is lipid-rich with a nonoccluding
hrombus superimposed. (B)Higher magnification of the plaque-thrombus
nterface reveals that the fibrous cap over the lipid-rich core is extremely
hin, inflamed, and ruptured with a real defect—a gap—in the cap. Both
rteries contain contrast medium injected postmortem. Trichrome stain,
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April 18, 2006:C7–12 Pathogenesis of Atherosclerosisescribed in thrombosed coronary plaques, probably re-
ruited as a response to plaque rupture (18).
The mere adhesion to the endothelium is, of course, not
nough for blood-borne cells to arrive in the lesion, trans-
ndothelial migration also is required. As to that, one or
ore chemokines (chemotactic cytokines) are necessary. Ex-
erimental studies indicate that the most important athero-
enic chemoattractants are oxidized LDL and MCP-1 (12).
onocyte chemotactic protein-1 is a powerful chemokine and
ts receptor on monocyte/macrophages (CCR2) may be
p-regulated enormously during plaque development, from
3,000/cell in the resting state to 60,000/cell when
timulated. Monocyte chemotactic protein-1 attracts po-
ently both monocytes and T cells (but not neutrophils and
cells) and most likely plays a fundamental role in the
ecruitment of these cells. Endothelial cells, smooth muscle
ells, and macrophages all contribute to overexpression of
CP-1 in atherosclerosis. Thus, once within the intima,
onocyte-derived macrophages may recruit themselves by
ecreting MCP-1. Cytokines (e.g., interleukin-8) also may
lay a role in monocyte-macrophage trafficking (5).
Within intima, the monocytes differentiate into macro-
hages and internalize the atherogenic lipoproteins via so-
alled scavenger receptors, of which SR-A and CD36 have
een demonstrated to play quantitatively significant roles in
xperimental atherosclerosis. The development of lipid-loaded
acrophages containing massive amounts of cholesteryl esters
foam cells) is a hallmark of both early and late atherosclerotic
esions. With continuing supply of atherogenic lipoproteins,
he macrophages eat until they die because, in contrast to the
ative LDL receptor, scavenger receptors are not down-
egulated by cellular cholesterol accumulation. The death of
acrophages by apoptosis and necrosis contributes to the
ormation of a soft and destabilizing lipid-rich core within the
laque. On the other hand, macrophages may under appropri-
te conditions (low LDL and high HDL) shrink by effluxing
ellular cholesterol to extracellular HDL via membrane trans-
orters, the initial step in “reverse cholesterol transport” (5–7).
side from their scavenger function, macrophages also possess
estabilizing and thrombogenic properties by expressing
atrix-degrading proteolytic enzymes (e.g., matrix metallopro-
einases) and tissue factor (12). Thus, these innate protective
ells initially recruited to combat cytotoxic lipids, turn into
evastating friendly fire during the progression of athero-
hrombosis.
Immune activation is ongoing in atherosclerotic lesions
13,19). Although lymphocytes are not required for the
evelopment of atherosclerosis, the immune system modu-
ates the progression of the disease. There are a number of
andidate antigens in the lesion that could be responsible for
mmune activation, including modified LDL, heat-shock
roteins, beta-2-glycoprotein I, and microbial antigens. Of
hese, the most extensive data support an important role for
xidized LDL, which is abundantly present in atheroscle-
otic plaques, where it is recognized by T cells (13,19). The
p-regulated expression of the immune mediator CD40 and
i
sts ligand CD154 by all cell types present in advanced
therosclerotic lesions promotes lesion formation in
therosclerosis-prone mice (13).
mooth muscle cells. Only endothelial cells, macrophages,
nd a few T cells participate in the development of the early
nd asymptomatic foam-cell lesion, the fatty streak. In disease
rogression, the immunoinflammatory response is joined by a
broproliferative response mediated by intimal smooth muscle
ells. These cells are responsible for healing and repair after
rterial injury. If the atherogenic stimuli persist over the
ourse of years, as they often do, the reparative response may
ecome so voluminous and dominating that lumen is lost,
lood flow is reduced, and ischemia sets in (Fig. 2) (20).
evertheless, smooth muscle cells and the collagen-rich
atrix they produce do confer stability to plaques, protect-
ng them against much more ominous consequences; plaque
upture and thrombosis (21).
The smooth muscle cell is the principal connective tissue-
roducing cell in the normal (the “soil”) and diseased
atherosclerotic) intima (21). Because of the repairing and
rotective capabilities of smooth muscle cells, their recruit-
ent, proliferation, and synthetic activities are considered
eneficial, whereas senescence, impaired function, and/or
eath of these cells most likely are detrimental, suggested by
he local loss of smooth muscle cells where plaques tear
part (rupture). It is unknown why smooth muscle cells are
acking at rupture sites, but apoptotic cell death could play
n important role (22,23).
PECIAL FEATURES OF ATHEROSCLEROTIC PLAQUES
ipid-rich core. Early in atherogenesis, the atherogenic
ipoproteins are cleared from the intima by the scavenging
acrophages, giving rise to intracellular lipid accumulation
foam cell formation). This in-principle protective function
ay be overwhelmed and turned into a detrimental disease-
igure 2. Average composition of advanced coronary plaque. Pie diagram
llustrating the average composition of advanced atherosclerotic plaques
75% stenosis by histology) in the coronary artery tree in fatal myocardial
nfarction (20). Hypocellular tissues (fibrosis, calcium, and necrosis) con-
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Pathogenesis of Atherosclerosis April 18, 2006:C7–12ausing pathway when the foam cells die and leave the lipid
ehind as a soft, destabilizing, and rather inert necrotic
atheromatous) core within the plaque (Fig. 1).
Atherogenic lipoproteins also may be retained and accu-
ulate within intima without first passing through foam
ells (24). The lipid-rich atheromatous core is avascular,
ypocellular, soft-like gruel, and totally devoid of support-
ng collagen. Its size is, of course, critical for the stability of
plaque.
ell death. During the progression of atherosclerosis, en-
othelial cells, macrophages, and smooth muscle cells die by
poptosis or necrosis (the former probably prevails). Disin-
egration of foam cells and loss of smooth muscle cells may
ave detrimental consequences, leading to the formation of
destabilizing lipid-rich core and a fragile and rupture-
rone fibrous cap (22). Furthermore, apoptosis contributes
ramatically to the high tissue factor activity and thrombo-
enicity of the lipid-rich core (25). The paradoxical obser-
ation that a plaque may growth even though cell death
ppears to exceed cell proliferation is probably because cell
enewal is mediated by influx (recruitment) of new cells
ather than local cell division. During regression of athero-
clerosis induced by cholesterol lowering in animals, inflam-
atory cells (macrophages) disappear, but their fate remains
lusive. Many macrophages appear to die within the lesion,
ut others probably emigrate from regressive plaques (26).
alcification. Focal calcification in atherosclerotic plaques
s very common and increases with age (27). The total
mount of calcification—the coronary artery calcium
core—is a genuine marker of coronary plaque burden and
rovides prognostic information beyond that provided by
raditional risk factor scoring (28). Plaque calcification is to
ome extent active and controlled, resembling calcification in
Table 1. Worldwide, 1,114 (76%) of 1,460 Fat
by Plaque Rupture
Patients Age (yrs)* n
Hospital, — — 19
Hospital, — — 17
Hospital, AMI  SCD 58 40
Hospital, AMI 62 88
Hospital, AMI 66 91
Coroner, SCD 53 20
Hospital, AMI 67 76
Hospital, AMI 67 49
Coroner, SCD 65 32
Medical exam, SCD 70 61
Hospital, AMI — 83
Coroner, — — 85
Hospital, AMI 63 20
Coroner, SCD — 202
Hospital, AMI 69 291
Hospital, AMI 61 61
Hospital, AMI 69 100
Medical exam, SCD 48 125
Total AMI  SCD 1,460*Mean. †For details, see Falk et al. (41).
—  not reported; AMI  acute myocardial infarction; SCDone, and both lipid and connective tissue may calcify. In
oronary arteries, calcification is almost always caused by
therosclerosis; medial calcification (Mönckeberg’s calcinosis)
s exceedingly rare. Clinical observations suggest that culprit
esions responsible for acute coronary syndromes generally are
ess calcified than plaques responsible for stable angina, and the
attern of plaque calcification also differs (29,30).
eovascularization and intraplaque hemorrhage. Angio-
enesis is frequent in advanced atherosclerosis. It is probably
marker of ongoing disease activity and may thus charac-
erize high-risk plaques (31–34). Endothelial proliferation
nd sprouting usually originates from vasa vasorum in adven-
itia and extends through media into the base of the plaque,
here neovascularization is most conspicuous. The new mi-
rovessels are fragile, are leaky, and express cellular adhesion
olecules (VCAM-1, intercellular adhesion molecule-1), re-
ulting in local extravasation of plasma proteins, erythrocytes
bleeding), and inflammatory cells. Thus, angiogenesis and
nflammation often coexist and could mediate rapid plaque
rogression (31–34). Regardless of the integrity of the
laque surface, extravasated erythrocytes are common in
eovascularized areas, but there is no convincing evidence
hat these low-pressure bleedings may precipitate rupture of
he plaque surface and/or acute luminal thrombosis (35).
eovascularization disappears with plaque regression in-
uced by cholesterol lowering in animals.
ascular remodeling and luminal stenosis. During plaque
evelopment, remodeling of the artery takes place, in which
he flow-limiting potential of the intimal plaque may be
ttenuated (expansive remodeling) or accentuated (constric-
ive remodeling) by reactive changes in the underlying vessel
all. Plaques assumed to be rupture-prone (so-called in-
amed thin-cap fibroatheroma) and those responsible for
oronary Thrombi Were Precipitated
Rupture Study†
19  100% Chapman, 1965
17  100% Constantinides, 1966
39  98% Friedman et al., 1966
71  81% Bouch et al., 1970
68  75% Sinapius, 1972
19  95% Friedman et al., 1973
69  91% Horie et al., 1978
40  82% Falk, 1983
26  81% Tracy et al., 1985
39  64% El Fawal et al., 1987
52  63% Yutani et al., 1987
71  84% Richardson et al., 1989
12  60% van der Wal et al., 1994
143  71% Davies, 1997
218  75% Arbustini et al., 1999
56  92% Shi et al., 1999
81  81% Kojima et al., 2000
74  59% Virmani et al., 2000
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April 18, 2006:C7–12 Pathogenesis of Atherosclerosiscute coronary syndromes usually are relatively large and
ssociated with expansive remodeling, which tends to pre-
erve a normal lumen. In contrast, plaques responsible for
table angina usually are smaller but, nevertheless, often are
ssociated with more severe luminal narrowing because of
oncomitant constrictive remodeling (36). Smoking and
iabetes mellitus have been linked to constrictive remodel-
ng but, otherwise, the reason for these different modes of
emodeling is unknown. Experimental studies indicate that
rocesses in adventitia could play a decisive role in
emodeling.
laque rupture. The term plaque rupture is used for “A
laque with deep injury with a real defect or gap in the
brous cap that had separated its lipid-rich atheromatous
ore from the flowing blood, thereby exposing the throm-
ogenic core of the plaque” (37). This is the most common
ause of coronary artery thrombosis.
onfatal thrombosis. Plaque rupture is not a rare event in
he development of coronary atherosclerosis. It is particu-
arly frequent and often multiple in acute coronary syn-
romes (38). Rupture of the plaque surface is followed by
ariable amounts of hemorrhage into the plaque and luminal
hrombosis, causing sudden and rapid but often clinically
ilent progression of the lesion. It is probably the most
mportant mechanism underlying the episodic (versus lin-
ar) progression of coronary lesions observed by serial
ngiography (39,40).
atal thrombosis. A recent extensive review of the litera-
ure revealed that plaque rupture is responsible for 76% of all
atal heart attacks caused by coronary thrombosis worldwide
Table 1) (41). The remaining 24% are caused by plaque
rosion and other less well-defined mechanisms. Plaque
upture is a more frequent cause of coronary thrombosis in
en (80%) than in women (60%). Except for gender
nd menopause, no particular risk factors consistently have
een connected with a particular type of coronary plaque or
echanism of thrombosis.
Pathoanatomical features of ruptured plaques and, by
nference, plaques assumed to be rupture-prone (vulnerable)
re shown in Table 2, and potential targets for their
able 2. Features Associated With Plaque Rupture
Structural
Large and soft lipid-rich core
Thin and collagen-poor fibrous cap
Cellular
Lack of SMCs at rupture site
Accumulation of MACRs at rupture site
Function
Impaired matrix synthesis (SMC-related)
Increased matrix breakdown (MACR-derived MMPs)
Remodeling
Expansive (outward) vascular remodeling
Others
Adventitial inflammation and neovascularization
ACR  macrophages; MMP  matrix metalloproteinase; SMC  smooth muscle
ell.etection by imaging are highlighted in Figure 3.
e
librin and platelets. During atherogenesis, multiple sites
f endothelial denudation and plaque rupture develop and
eal. When subendothelial tissue is exposed, platelets ad-
ere and fibrin forms. The magnitude of this thrombotic
esponse depends on the thrombogenic stimulus; plaque
upture probably is much more thrombogenic than plaque
rosion. In the pathogenesis of arterial thrombosis, platelet
ggregation is responsible for the initial flow obstruction but
brin formation is necessary for the subsequent stabilization
f the platelet-rich thrombosis. Thus, both platelets and
brin may accumulate over ruptured and eroded plaques.
ontribution of bone marrow-derived cells. Bone marrow-
erived macrophages play a critical role in the initiation and
rogression of atherosclerosis. However, conventional wis-
om says that endothelial cells and intimal smooth muscle
ells reside within the arterial wall and proliferate, migrate,
nd secrete what might be needed for expedient healing and
epair after injury (21). Therefore, it came as an incredible
igure 3. Molecular and structural targets for imaging. Cross section of a
oronary artery containing plaque assumed to be rupture-prone. Potential
argets for imaging are highlighted. They comprise: 1) the large lipid-rich
ecrotic core (orange asterisk), 2) thin fibrous cap (blue arrows), 3)
xpansive remodeling (green arrow), and 4) vasa vasorum and neovascu-
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Pathogenesis of Atherosclerosis April 18, 2006:C7–12urprise when experimental studies suggested that many of
he healing smooth muscle cells originated in the bone
arrow and were brought to the injured vessel wall with the
irculating blood (42). Supportive human observations also
ave been published, and the challenge is to use this potential
n the retardation and stabilization of atherosclerosis in humans
43,44). Mobilization of atheroprotective cells from the bone
arrow and promoting their homing to thrombosis-prone
laques may be a new way to stabilize atherosclerosis against
hrombosis and its devastating consequences.
eprint requests and correspondence: Dr. Erling Falk, De-
artment of Cardiology, Aarhus University Hospital (Skejby),
rendstrupgaardsvej, DK-8200 Aarhus N, Denmark. E-mail:
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